StonvexLoading…
StonvexCore line items from A's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $1.80B | $6.95B | $5.09B | $3.35B |
Operating Income | $353.00M | $1.48B | $1.04B | $676.00M |
Net Income | $305.00M | $1.30B | $869.00M | $533.00M |
EPS (Diluted) | $1.07 | $4.57 | $3.05 | $1.86 |
Total Assets | $12.81B | $12.73B | $12.23B | $12.16B |
Total Liabilities | $5.91B | $5.99B | $5.86B | $6.02B |
Cash & Equivalents | $1.76B | $1.79B | $1.53B | $1.49B |
Free Cash Flow OCF − CapEx | $175.00M | $1.15B | $700.00M | $441.00M |
Shares Outstanding | 282.70M | 283.05M | 283.59M | 283.94M |